Comparative efficacy and safety of stimulant-type medications for depression: A systematic review and network meta-analysis

2021/06/15 by Anees Bahji, Lia Mesbah-Oskui · 1 citation
Medicine · Neuroscience · Psychology · #Digital Mental Health Interventions #Neurotransmitter Receptor Influence on Behavior #Treatment of Major Depression

paper · doi:10.1016/j.jad.2021.05.119

openalex publication_date 2021/06/15 · crossref created 2021/06/15 · crossref issued 2021/09/01 · crossref published 2021/09/01 · crossref published-print 2021/09/01 · crossref deposited 2025/09/28 · openalex created_date 2025/10/10 · crossref indexed 2026/06/04 · openalex updated_date 2026/07/28

Citations

• The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
• Osmotic-Release Oral System Methylphenidate Augmentation of Antidepressant Monotherapy in Major Depressive Disorder
• Modafinil Augmentation Therapy in Unipolar and Bipolar Depression
• Evaluation of networks of randomized trials
• Statistical power analysis for the behavioral sciences
• The Epidemiology of Depression Across Cultures
• Stimulants for depression: On the up and up?
• Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
• The Efficacy of Psychostimulants in Major Depressive Episodes
• Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
• Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

Cited by

• Modafinil [wikipedia]